[1]AppliedOrganometallicChemistry,2014,vol.28,p.54-60
[2]Chemistry-AEuropeanJournal,2004,vol.10,p.1789-1797
[1]EuropeanJournalofMedicinalChemistry,2007,vol.42,p.293-306
[1]Patent:WO2011/52516,2011,A1.Locationinpatent:Page/Pagecolumn150-151
114772-33-7
120-33-2
147404-69-1
158619-46-6
168618-46-0
1751-97-9
19962-37-9 | 2-Acetamido-6-hydroxypurine | AA002C6F | MFCD00078201
200190-87-0 | 1-Bromo-4-chloro-2-fluoro-5-methylbenzene | AA002CIF | MFCD09800685
20059-73-8 | 4-[2-(Dimethylamino)ethoxy]benzylamine | AA002CRY | MFCD01075231
201046-61-9 | Fmoc-orn(pyrazic)-oh | AA002D3G | MFCD00672336
201478-72-0 | Benzyl 3-formylpiperidine-1-carboxylate | AA002DD7 | MFCD02179022
1897-41-2 | 2,3,5,6-Tetrachloroterephthalonitrile | AA002DUK | MFCD00059583
19026-22-3 | D-Gluconic acid, 2-(acetylamino)-2-deoxy-, δ-lactone | AA002ECX | MFCD00076154
19074-24-9 | Dodecanedioic acid, 1,12-bis(2-ethylhexyl) ester | AA002EP8 | MFCD00144216
1912-48-7 | 1-Methyl-3-indoleacetic acid | AA002F1C | MFCD00130160
191671-46-2 | Hexanoic acid, 6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-, 2,5-dioxo-3-sulfo-1-pyrrolidinyl ester, sodium salt (1:1) | AA002FC9 | MFCD00078534